Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-06-18

Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation

Article Category

Article available in the following languages:

Mouse models contribute to understanding human health and disease

The mouse is similar to humans in terms of development, physiology and its underlying genome. European researchers have therefore developed mouse mutant models to investigate genes implicated in the whole spectrum of human disease.

The EU-funded project INFRAFRONTIER-I3 project has preserved and supplied mouse models to relevant European and global research communities. New disease models were developed, phenotyped and archived, and are now accessible in the European Research Area (ERA) and beyond. The initiative involved free-of-charge access to lines and phenotyping as well as provision of germ-free mice. Standard operating procedures for phenotyping and cryopreservation were developed and training courses offered in these two areas. New lines were stored in the European Mouse Mutant Archive (EMMA). Strains were donated from across Europe, with major contributions from Germany, France and the United Kingdom. Overall, 23 partners from 16 countries comprised the INFRAFRONTIER-I3 consortium, including a total of 16 EMMA nodes representing 14 countries. The project was a collaborative effort, carrying transnational access calls for mouse production projects. The most promising proposals led to the development of 29 new mouse models of human diseases, covering a wide range of key research areas such as cancer and diabetes, amongst others. Resources and services were benchmarked with other major mouse repositories and included free archiving of mice in EMMA, a mouse ordering service, and mouse production and phenotyping for European researchers. There was also a search facility for EMMA strains by type, genes and human diseases. Ultimately, 1 215 new mouse mutant lines were archived in EMMA, supporting its development as the third largest mouse repository, holding 6 000 mouse mutants. This unique resource will enable European researchers to investigate molecular mechanisms behind disease and therapeutic solutions. INFRAFRONTIER-I3 efforts will promote a more coordinated approach between infrastructure operators, users and public authorities, and global initiatives such as the International Mouse Phenotyping Consortium (IMPC). In addition, closer interaction between researchers will facilitate the wider sharing of knowledge and techniques across scientific fields and between academia and industry.

Keywords

Mouse models, human disease, INFRAFRONTIER-I3, phenotyping, European Mouse Mutant Archive

Discover other articles in the same domain of application